Editas Medicine Inc.

NASDAQ: EDIT
Share price (8/14/25): $2.96
Market cap (8/14/25): $266 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Updated info for already-effective prospectus

Post-effective amendment to an automatic shelf registration

Automatic shelf registration

Registration of securities for employees

Ownership Filter

Hopfield Jessica

News Filter

Announces Second Quarter 2025 Results and Business Updates

Achieved 58% Mean Editing at Five Months After a Single Dose Using High Efficiency HSC Delivery, Demonstrating Therapeutically Relevant Editing Levels Using a Clinically Validated Strategy

Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Reports New in Vivo Data Highlighting the Potential of Editas’ Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting

Reports New in Vivo Proof of Concept Data in an Undisclosed Liver Target at the American Society of Gene and Cell Therapy Annual Meeting

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Confidential treatment order

Confidential treatment order